Glycopyrrolate Injection
Product Images NDC 71288-415

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71288-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gly0a 0001 01 V2)

Chemical structure of Glycopyrrolate showing its molecular composition including a bicyclic structure, hydroxyl group, ester linkage, and a quaternary ammonium group with a bromide ion.*

FDA Label Image

Principal Display Panel – Glycopyrrolate Injection, Usp 1 mL Container Label (Gly0a 0001 02 V2)

Glycopyrrolate Injection, USP 0.2 mg/mL single-dose vial label by Meitheal Pharmaceuticals Inc. Indicates intramuscular or intravenous use, contains benzyl alcohol, and is made in China. Includes NDC 71288-414-01, barcode, lot, and expiration date fields.*

FDA Label Image

Principal Display Panel – Glycopyrrolate Injection, Usp 1 mL Carton (Gly0a 0001 03 V2)

Foldable carton label for Glycopyrrolate Injection, USP 0.2 mg per mL, a human prescription drug for intramuscular or intravenous use by Meitheal Pharmaceuticals Inc. The label indicates a package of 25 single-dose 1 mL vials, highlights that it contains benzyl alcohol, and includes storage instructions and barcodes.*

FDA Label Image

Principal Display Panel – Glycopyrrolate Injection, Usp 2 mL Container Label (Gly0a 0001 04 V2)

Glycopyrrolate Injection, USP label showing a strength of 0.4 mg per 2 mL (0.2 mg per mL) in a single-dose vial. The label indicates it contains benzyl alcohol and is for intramuscular or intravenous use. Manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL, made in China. Includes NDC 71288-414-02 and space for lot and expiration dates.*

FDA Label Image

Principal Display Panel – Glycopyrrolate Injection, Usp 2 mL Carton (Gly0a 0001 05 V2)

Packaging label for Glycopyrrolate Injection, USP, 0.4 mg per 2 mL (0.2 mg per mL) by Meitheal Pharmaceuticals Inc. The label includes strength, dosage form, route of administration (intramuscular or intravenous), a warning 'Not for use in newborns,' and states it contains benzyl alcohol. The package contains 25 single-dose vials of 2 mL each.*

FDA Label Image

Principal Display Panel – Glycopyrrolate Injection, Usp 5 mL Container Label (Gly0a 0001 06 V2)

Label for Glycopyrrolate Injection USP, 0.2 mg/mL (1 mg per 5 mL) in a 5 mL multi-dose vial. The label indicates use for intramuscular or intravenous administration, contains benzyl alcohol preservative, and notes it is not for use in newborns. Manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL, and made in China.*

FDA Label Image

Principal Display Panel – Glycopyrrolate Injection, Usp 5 mL Carton (Gly0a 0001 07 V3)

Carton packaging for Glycopyrrolate injection USP, 1 mg per 5 mL (0.2 mg per mL), for intramuscular or intravenous use. The package contains 25 vials of 5 mL each. Manufactured by Meitheal Pharmaceuticals Inc. The label includes storage instructions, formulation details, and a warning that the product contains benzyl alcohol and is not for use in newborns.*

FDA Label Image

Principal Display Panel – Glycopyrrolate Injection, Usp 20 mL Container Label (Gly0a 0001 08 V3)

Glycopyrrolate Injection, USP 0.2 mg/mL (4 mg per 20 mL) multi-dose vial label. The injectable solution is for intramuscular or intravenous use and contains benzyl alcohol as a preservative. The label includes storage instructions (20° to 25°C), cautions about use in newborns, and manufacturer information for Meitheal Pharmaceuticals Inc.*

FDA Label Image

Principal Display Panel – Glycopyrrolate Injection, Usp 20 mL Carton (Gly0a 0001 09 V2)

Glycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg per mL) multi-dose vial packaging label from Meitheal Pharmaceuticals Inc. The label indicates it contains benzyl alcohol and is for intramuscular or intravenous use, with storage instructions and manufacturer information included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.